Healthcare Global - December 2014

Page 54

ASTRAZENECA MExico

Future developments for AZ Mexico include the release of about a dozen new medicines over the next five years

great accomplishment considering the national competitive level in the pharmaceutical industry and its relatively recent presence in Mexico (since 1999). The company has a tendency to rise in the rankings thanks to various scientific development programs led in Mexico, such as the establishment of partnerships with organizations, institutions and professionals dedicated to medical research, and the support of medical advancement projects in the country. AstraZeneca invested USD $4 million in research and development projects in Mexico 54

December 2014


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.